These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 7848592

  • 1. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial.
    Garcia Compean D, Ramos Jimenez J, Guzman de la Garza F, Saenz C, Maldonado H, Barragan RF, Michel H.
    AIDS; 1994 Nov; 8(11):1563-7. PubMed ID: 7848592
    [Abstract] [Full Text] [Related]

  • 2. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial.
    Cello JP, Grendell JH, Basuk P, Simon D, Weiss L, Wittner M, Rood RP, Wilcox CM, Forsmark CE, Read AE.
    Ann Intern Med; 1991 Nov 01; 115(9):705-10. PubMed ID: 1929038
    [Abstract] [Full Text] [Related]

  • 3. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea.
    Simon DM, Cello JP, Valenzuela J, Levy R, Dickerson G, Goodgame R, Brown M, Lyche K, Fessel WJ, Grendell J.
    Gastroenterology; 1995 Jun 01; 108(6):1753-60. PubMed ID: 7768380
    [Abstract] [Full Text] [Related]

  • 4. Octreotide treatment in secretory and cyrptosporidial diarrhea in patients with acquired immunodeficiency syndrome (AIDS): clinical evaluation.
    Liberti A, Bisogno A, Izzo E.
    J Chemother; 1992 Oct 01; 4(5):303-5. PubMed ID: 1479420
    [Abstract] [Full Text] [Related]

  • 5. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E, Karaoglu A.
    Oncology; 2006 Oct 01; 71(5-6):354-60. PubMed ID: 17873499
    [Abstract] [Full Text] [Related]

  • 6. Octreotide acetate in refractory bone marrow transplant-associated diarrhea.
    Crouch MA, Restino MS, Cruz JM, Perry JJ, Hurd DD.
    Ann Pharmacother; 1996 Apr 01; 30(4):331-6. PubMed ID: 8729883
    [Abstract] [Full Text] [Related]

  • 7. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.
    Cascinu S, Fedeli A, Fedeli SL, Catalano G.
    J Clin Oncol; 1993 Jan 01; 11(1):148-51. PubMed ID: 8418225
    [Abstract] [Full Text] [Related]

  • 8. Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy.
    Gebbia V, Carreca I, Testa A, Valenza R, Curto G, Cannata G, Borsellino N, Latteri MA, Cipolla C, Florena M.
    Anticancer Drugs; 1993 Aug 01; 4(4):443-5. PubMed ID: 8400346
    [Abstract] [Full Text] [Related]

  • 9. Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995.
    Füessl HS, Zoller WG, Kochen MM, Bogner JR, Heinrich B, Matuschke A, Goebel FD.
    Klin Wochenschr; 1989 Apr 17; 67(8):452-5. PubMed ID: 2724869
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of diarrhea with loperamide in palliative medicine. A systematic review].
    Pastrana T, Meißner W.
    Schmerz; 2013 Apr 17; 27(2):182-9. PubMed ID: 23475156
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study.
    Yavuz MN, Yavuz AA, Aydin F, Can G, Kavgaci H.
    Int J Radiat Oncol Biol Phys; 2002 Sep 01; 54(1):195-202. PubMed ID: 12182992
    [Abstract] [Full Text] [Related]

  • 12. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
    Rosenoff S.
    Support Care Cancer; 2004 Aug 01; 12(8):561-70. PubMed ID: 15160318
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
    Geller RB, Gilmore CE, Dix SP, Lin LS, Topping DL, Davidson TG, Holland HK, Wingard JR.
    Am J Hematol; 1995 Nov 01; 50(3):167-72. PubMed ID: 7485077
    [Abstract] [Full Text] [Related]

  • 14. Octreotide in the treatment of refractory diarrhea.
    Fried M.
    Digestion; 1999 Nov 01; 60 Suppl 2():42-6. PubMed ID: 10207230
    [Abstract] [Full Text] [Related]

  • 15. Octreotide for symptomatic treatment of diarrhea due to cytomegalovirus colitis.
    Bartels MC, Mergenhagen KA.
    Ann Pharmacother; 2011 Jan 01; 45(1):e4. PubMed ID: 21189368
    [Abstract] [Full Text] [Related]

  • 16. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.
    Mystakidou K, Katsouda E, Tsilika E, Smyrniotis V, Vassiliou I, Tsiatas M, Vlahos L.
    Anticancer Res; 2006 Jan 01; 26(3B):2325-8. PubMed ID: 16821610
    [Abstract] [Full Text] [Related]

  • 17. Pilot study of sandostatin (octreotide) therapy of refractory HIV-associated diarrhea.
    Fanning M, Monte M, Sutherland LR, Broadhead M, Murphy GF, Harris AG.
    Dig Dis Sci; 1991 Apr 01; 36(4):476-80. PubMed ID: 2007364
    [Abstract] [Full Text] [Related]

  • 18. Control of irinotecan-induced diarrhea by octreotide after loperamide failure.
    Barbounis V, Koumakis G, Vassilomanolakis M, Demiri M, Efremidis AP.
    Support Care Cancer; 2001 Jun 01; 9(4):258-60. PubMed ID: 11430421
    [Abstract] [Full Text] [Related]

  • 19. A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS.
    Holodniy M, Koch J, Mistal M, Schmidt JM, Khandwala A, Pennington JE, Porter SB.
    Am J Gastroenterol; 1999 Nov 01; 94(11):3267-73. PubMed ID: 10566728
    [Abstract] [Full Text] [Related]

  • 20. Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue.
    Kreinik G, Burstein O, Landor M, Bernstein L, Weiss LM, Wittner M.
    AIDS; 1991 Jun 01; 5(6):765-7. PubMed ID: 1883548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.